Phoenix Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,110
Closed -$410K 386
2024
Q4
$410K Buy
1,110
+104
+10% +$43.5K 0.01% 273
2024
Q3
$524K Buy
+1,006
New +$537K 0.01% 247
2022
Q1
Sell
-4,633
Closed -$2.15M 420
2021
Q4
$2.15M Sell
4,633
-84
-2% -$35.3K 0.04% 191
2021
Q3
$1.77M Buy
+4,717
New +$1.79M 0.03% 223
2021
Q2
Sell
-4,015
Closed -$1.45M 332
2021
Q1
$1.45M Buy
+4,015
New +$1.29M 0.03% 257

Other funds holding ELV

Phoenix Financial's ELV Position: Q1 2025 in Review

Phoenix Financial sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 1,110 shares — an estimated $410K sold.

Phoenix Financial first reported a position in ELV in Q1 2021 and held it in 5 quarters. The position peaked at $2.15M in Q4 2021. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Phoenix Financial reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Phoenix Financial sold 1,110 Elevance Health shares in Q1 2025, an estimated $410K.
  • Phoenix Financial first reported a position in Elevance Health in Q1 2021 and held it in 5 quarters.
  • Phoenix Financial's Elevance Health position peaked at $2.15M in Q4 2021.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Phoenix Financial's 13F filing for Q1 2025, filed 7 May 2025.